
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Ouro Fino Saude Animal Participacoes SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
16.01
24.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Ouro Fino Saude Animal Participacoes SA hold over its rivals?
What risks and challenges
does Ouro Fino Saude Animal Participacoes SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Ouro Fino Saude Animal Participacoes SA.
Provide an overview of the primary business activities
of Ouro Fino Saude Animal Participacoes SA.
What unique competitive advantages
does Ouro Fino Saude Animal Participacoes SA hold over its rivals?
What risks and challenges
does Ouro Fino Saude Animal Participacoes SA face in the near future?
Summarize the latest earnings call
of Ouro Fino Saude Animal Participacoes SA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Ouro Fino Saude Animal Participacoes SA.
Provide P/S
for Ouro Fino Saude Animal Participacoes SA.
Provide P/E
for Ouro Fino Saude Animal Participacoes SA.
Provide P/OCF
for Ouro Fino Saude Animal Participacoes SA.
Provide P/FCFE
for Ouro Fino Saude Animal Participacoes SA.
Provide P/B
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/S
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/GP
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/EBITDA
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/EBIT
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/OCF
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/FCFF
for Ouro Fino Saude Animal Participacoes SA.
Provide EV/IC
for Ouro Fino Saude Animal Participacoes SA.
Show me price targets
for Ouro Fino Saude Animal Participacoes SA made by professional analysts.
What are the Revenue projections
for Ouro Fino Saude Animal Participacoes SA?
How accurate were the past Revenue estimates
for Ouro Fino Saude Animal Participacoes SA?
What are the Net Income projections
for Ouro Fino Saude Animal Participacoes SA?
How accurate were the past Net Income estimates
for Ouro Fino Saude Animal Participacoes SA?
What are the EPS projections
for Ouro Fino Saude Animal Participacoes SA?
How accurate were the past EPS estimates
for Ouro Fino Saude Animal Participacoes SA?
What are the EBIT projections
for Ouro Fino Saude Animal Participacoes SA?
How accurate were the past EBIT estimates
for Ouro Fino Saude Animal Participacoes SA?
Compare the revenue forecasts
for Ouro Fino Saude Animal Participacoes SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Ouro Fino Saude Animal Participacoes SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Ouro Fino Saude Animal Participacoes SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Ouro Fino Saude Animal Participacoes SA compared to its peers.
Compare the P/E ratios
of Ouro Fino Saude Animal Participacoes SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Ouro Fino Saude Animal Participacoes SA with its peers.
Analyze the financial leverage
of Ouro Fino Saude Animal Participacoes SA compared to its main competitors.
Show all profitability ratios
for Ouro Fino Saude Animal Participacoes SA.
Provide ROE
for Ouro Fino Saude Animal Participacoes SA.
Provide ROA
for Ouro Fino Saude Animal Participacoes SA.
Provide ROIC
for Ouro Fino Saude Animal Participacoes SA.
Provide ROCE
for Ouro Fino Saude Animal Participacoes SA.
Provide Gross Margin
for Ouro Fino Saude Animal Participacoes SA.
Provide Operating Margin
for Ouro Fino Saude Animal Participacoes SA.
Provide Net Margin
for Ouro Fino Saude Animal Participacoes SA.
Provide FCF Margin
for Ouro Fino Saude Animal Participacoes SA.
Show all solvency ratios
for Ouro Fino Saude Animal Participacoes SA.
Provide D/E Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide D/A Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide Interest Coverage Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide Altman Z-Score Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide Quick Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide Current Ratio
for Ouro Fino Saude Animal Participacoes SA.
Provide Cash Ratio
for Ouro Fino Saude Animal Participacoes SA.
What is the historical Revenue growth
over the last 5 years for Ouro Fino Saude Animal Participacoes SA?
What is the historical Net Income growth
over the last 5 years for Ouro Fino Saude Animal Participacoes SA?
What is the current Free Cash Flow
of Ouro Fino Saude Animal Participacoes SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Ouro Fino Saude Animal Participacoes SA.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
BR |
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
1.2B BRL | 1.4 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD | 47.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 17 702.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD | 17.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 15.6 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF | 13.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP | 193.9 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD | 10.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF | 14.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 670.8 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD | 12.1 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
BR |
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
Average EV/EBIT:
1 699.9
1.4
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
47.2
|
33%
|
1.4 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
17 702.3
|
98%
|
180.6 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
17.2
|
12%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
15.6
|
16%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
13.6
|
9%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
193.9
|
21%
|
9.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
10.5
|
12%
|
0.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
14.7
|
8%
|
1.8 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
670.8
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
12.1
|
10%
|
1.2 |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.